ALK and non-small cell lung carcinoma: In vitro studies have shown that in NSCLC cell lines carrying ALK-CNG are sensitive to ALK inhibitors, although, to the best of our knowledge, a possible role of ALK-A has not yet been fully clarified in NSCLC patients.